Who Supplies Glibenclamide? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Glibenclamide exports, with 194+ registered manufacturers shipping to buyers across 100+ countries — yet a handful of companies dominate the shipments. MEDOPHARM holds the largest share at 89.7% (export value: $37.0M). Close behind, CAPLIN POINT LABORATORIES LIMITED (0.6%, $254.2K). SUN PHARMACEUTICAL INDUSTRIES LIMITED (0.6%, $251.1K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Glibenclamide? Top Manufacturers & Their Buyers
Flow of Glibenclamide from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Glibenclamide Supplier Network — Key Market Intelligence
The Glibenclamide export market from India is led by MEDOPHARM, which alone commands a 89.7% share, shipping $37.0M worth of product across 48 shipments. The second-largest exporter, CAPLIN POINT LABORATORIES LIMITED, contributes $254.2K (0.6%) to the overall market. Combined, the top two suppliers alone account for 90.4% of all Glibenclamide exports, indicating a relatively concentrated supply base.
Across all 194 tracked manufacturers, the total Glibenclamide export value stands at $41.2M from 930 shipments. The market average shipment value is $44.3K. The single largest buyer relationship in terms of trade value is A,BAUR & CO,(PVT,) LTD, receiving $37.0M worth of product.
The combined buyer network spans 13 named purchasing companies, including A,BAUR & CO,(PVT,) LTD, XXSSIXXPHAXXA AXX VX, PJSC PHARMSTANDARD-TOMSKHIMPHARM, PHARMA VISION (PTY) , OPHAM and 8 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1MEDOPHARM
MEDOPHARM is the first-largest Glibenclamide exporter from India, with a market share of 89.7% and a total export value of $37.0M across 48 shipments. Their average shipment value of $770.4K is above the market average of $44.3K, suggesting premium or bulk contract pricing.
MEDOPHARM serves 1 named buyer in our database. A,BAUR & CO,(PVT,) LTD is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• A,BAUR & CO,(PVT,) LTD — $37.0M across 48 shipments (100.0% of this supplier's total exports)
Key Insight: MEDOPHARM's per-shipment value of $770.4K is 1639% above the market average of $44.3K, consistent with large-order contracts or value-added formulations.
2CAPLIN POINT LABORATORIES LIMITED
CAPLIN POINT LABORATORIES LIMITED is the second-largest Glibenclamide exporter from India, with a market share of 0.6% and a total export value of $254.2K across 17 shipments. Their average shipment value of $15.0K is below the market average of $44.3K, reflecting a high-volume, competitive pricing strategy.
CAPLIN POINT LABORATORIES LIMITED serves 1 named buyer in our database. XXSSIXXPHAXXA AXX VX is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• XXSSIXXPHAXXA AXX VX — $254.2K across 17 shipments (100.0% of this supplier's total exports)
Key Insight: CAPLIN POINT LABORATORIES LIMITED operates with high shipment frequency (17 shipments) at a per-shipment value of $15.0K, indicating a broad distribution network with many smaller, regular orders.
3SUN PHARMACEUTICAL INDUSTRIES LIMITED
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the third-largest Glibenclamide exporter from India, with a market share of 0.6% and a total export value of $251.1K across 9 shipments. Their average shipment value of $27.9K is below the market average of $44.3K, reflecting a high-volume, competitive pricing strategy.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 3 named buyers in our database. PJSC PHARMSTANDARD-TOMSKHIMPHARM is the dominant customer, accounting for 73.2% of this supplier's tracked business. Top customers include:
• PJSC PHARMSTANDARD-TOMSKHIMPHARM — $183.7K across 7 shipments (73.2% of this supplier's total exports)
• PJSC PHARMSTANDARD-TOMSKHIMPHARM — $63.3K across 2 shipments (25.2% of this supplier's total exports)
• PHARMA VISION (PTY) — $4.1K across 0 shipments (1.6% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED operates with high shipment frequency (9 shipments) at a per-shipment value of $27.9K, indicating a broad distribution network with many smaller, regular orders.
4LINCOLN PHARMACEUTICALS LTD
LINCOLN PHARMACEUTICALS LTD is the fourth-largest Glibenclamide exporter from India, with a market share of 0.4% and a total export value of $184.4K across 16 shipments. Their average shipment value of $11.5K is below the market average of $44.3K, reflecting a high-volume, competitive pricing strategy.
LINCOLN PHARMACEUTICALS LTD serves 4 named buyers in our database. OPHAM is the dominant customer, accounting for 82.6% of this supplier's tracked business. Top customers include:
• OPHAM — $152.3K across 13 shipments (82.6% of this supplier's total exports)
• SOMAPHAR SA — $24.1K across 2 shipments (13.1% of this supplier's total exports)
• OPHAM ANDRIAMAHAZO B — $5.3K across 0 shipments (2.9% of this supplier's total exports)
• OPHAM ROUTE DIGUE AN — $2.6K across 0 shipments (1.4% of this supplier's total exports)
Key Insight: LINCOLN PHARMACEUTICALS LTD operates with high shipment frequency (16 shipments) at a per-shipment value of $11.5K, indicating a broad distribution network with many smaller, regular orders.
5M. J. BIOPHARM PRIVATE LIMITED
M. J. BIOPHARM PRIVATE LIMITED is the fifth-largest Glibenclamide exporter from India, with a market share of 0.3% and a total export value of $143.0K across 10 shipments. Their average shipment value of $14.3K is below the market average of $44.3K, reflecting a high-volume, competitive pricing strategy.
M. J. BIOPHARM PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• UNDP ZAMBIA — $38.7K across 3 shipments (27.1% of this supplier's total exports)
• U.N.R.W.A. UNITED NA — $36.8K across 3 shipments (25.7% of this supplier's total exports)
• IMRES — $29.8K across 2 shipments (20.8% of this supplier's total exports)
• UNITED NATIONS RELIE — $18.9K across 1 shipments (13.2% of this supplier's total exports)
• MOPO TSYO-PATIENT IN — $18.9K across 1 shipments (13.2% of this supplier's total exports)
Key Insight: M. J. BIOPHARM PRIVATE LIMITED operates with high shipment frequency (10 shipments) at a per-shipment value of $14.3K, indicating a broad distribution network with many smaller, regular orders.
6CIPLA LIMITED
CIPLA LIMITED is the fifth-largest Glibenclamide exporter from India, with a market share of 0.3% and a total export value of $132.2K across 27 shipments. Their average shipment value of $4.9K is below the market average of $44.3K, reflecting a high-volume, competitive pricing strategy.
CIPLA LIMITED serves 3 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• TO THE ORDER — $63.1K across 13 shipments (47.7% of this supplier's total exports)
• NA — $44.6K across 9 shipments (33.7% of this supplier's total exports)
• TO THE ORDER OF — $24.5K across 5 shipments (18.5% of this supplier's total exports)
Key Insight: CIPLA LIMITED operates with high shipment frequency (27 shipments) at a per-shipment value of $4.9K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Glibenclamide Flows
Once Glibenclamide leaves the manufacturing plants of companies like MEDOPHARM and CAPLIN POINT LABORATORIES LIMITED, it travels to 5 destination markets with a combined import value of $41.2M. Sri Lanka absorbs the largest share at 89.8% ($37.0M), followed by Tanzania (1.6%) and Russia (1.2%).
In Sri Lanka — the top destination — named importers include A,BAUR & CO,(PVT,) LTD. In Tanzania, key buyers are HEKO PHARMACY LTD.
This geographic spread reflects Glibenclamide's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Glibenclamide Go? Top Importing Countries & Their Buyers
Trade flow of Glibenclamide exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Sri Lanka
Sri Lanka ranks as the first-largest destination for Glibenclamide imports from India, with a total trade value of $37.0M across 2 shipments — representing a 89.8% share of all Glibenclamide exports. The average shipment value of $18.5M is above the global average of $44.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Glibenclamide importers in Sri Lanka: A,BAUR & CO,(PVT,) LTD is the largest buyer, accounting for 100.0% ($37.0M) of this market's total imports.
• A,BAUR & CO,(PVT,) LTD — $37.0M (100.0% of Sri Lanka's total)
Key Insight: Sri Lanka's per-shipment average of $18.5M (41639% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Sri Lanka is a key market for Glibenclamide imports from India.
2Tanzania
Tanzania ranks as the second-largest destination for Glibenclamide imports from India, with a total trade value of $656.4K across 4 shipments — representing a 1.6% share of all Glibenclamide exports. The average shipment value of $164.1K is above the global average of $44.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Glibenclamide importers in Tanzania: HEKO PHARMACY LTD is the largest buyer, accounting for 8.2% ($54.1K) of this market's total imports.
• HEKO PHARMACY LTD — $54.1K (8.2% of Tanzania's total)
Key Insight: Tanzania's per-shipment average of $164.1K (270% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Tanzania is a key market for Glibenclamide imports from India.
3Russia
Russia ranks as the third-largest destination for Glibenclamide imports from India, with a total trade value of $475.8K across 7 shipments — representing a 1.2% share of all Glibenclamide exports. The average shipment value of $68.0K is above the global average of $44.3K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Glibenclamide importers in Russia: PJSC PHARMSTANDARD-TOMSKHIMPHARM is the largest buyer, accounting for 38.6% ($183.7K) of this market's total imports.
• PJSC PHARMSTANDARD-TOMSKHIMPHARM — $183.7K (38.6% of Russia's total)
• PJSC "PHARMSTANDARD-TOMSKHIMPHARM" — $116.3K (24.4% of Russia's total)
Key Insight: Russia's per-shipment average of $68.0K (53% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Russia is a key market for Glibenclamide imports from India.
4South Africa
South Africa ranks as the fourth-largest destination for Glibenclamide imports from India, with a total trade value of $469.0K across 25 shipments — representing a 1.1% share of all Glibenclamide exports. The average shipment value of $18.8K is below the global average of $44.3K, consistent with generic/API volume purchasing. This market is served by 5 tracked buyers.
Named Glibenclamide importers in South Africa: OETHMAAN BIOSIMS PTY LIMITED is the largest buyer, accounting for 24.4% ($114.5K) of this market's total imports.
• OETHMAAN BIOSIMS PTY LIMITED — $114.5K (24.4% of South Africa's total)
• BIOTECH LABORATORIES (PTY) LTD — $81.1K (17.3% of South Africa's total)
• OETHMAAN BIOSIMS PTY LTD — $69.2K (14.8% of South Africa's total)
Key Insight: South Africa receives frequent, smaller shipments of Glibenclamide — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
South Africa is a key market for Glibenclamide imports from India.
5Cambodia
Cambodia ranks as the fifth-largest destination for Glibenclamide imports from India, with a total trade value of $285.8K across 0 shipments — representing a 0.7% share of all Glibenclamide exports. The average shipment value of $285.8K is above the global average of $44.3K, indicating high-value procurement contracts or branded formulations.
Key Insight: Cambodia's per-shipment average of $285.8K (545% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Cambodia is a key market for Glibenclamide imports from India.
People Also Ask — Glibenclamide Supplier & Trade Network
Who are the top suppliers of Glibenclamide from India?+
Which companies buy Glibenclamide from Indian manufacturers?+
Where does Glibenclamide exported from India go?+
What is the market share of the top Glibenclamide supplier from India?+
What is the average shipment value for Glibenclamide exports from India?+
Is Glibenclamide manufactured in India and exported globally?+
Which country imports the most Glibenclamide from India?+
Who are the buyers of Glibenclamide in Tanzania?+
How concentrated is the Glibenclamide supplier market in India?+
How do I find verified buyers for Glibenclamide in specific countries?+
Glibenclamide Trade Network — Key Takeaways
- 1MEDOPHARM is India's dominant Glibenclamide exporter with a 89.7% market share and $37.0M in total exports — making it the single most important sourcing entity in this market.
- 2The top 194 suppliers collectively account for 92.1% of all tracked Glibenclamide exports, with a combined trade value of $41.2M.
- 3Sri Lanka is the largest destination market, absorbing 89.8% of India's Glibenclamide exports ($37.0M). Tanzania (1.6%) and Russia (1.2%) follow.
- 4With 930 total shipments averaging $44.3K each, the Glibenclamide export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include A,BAUR & CO,(PVT,) LTD, XXSSIXXPHAXXA AXX VX, PJSC PHARMSTANDARD-TOMSKHIMPHARM, PJSC PHARMSTANDARD-TOMSKHIMPHARM — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 1 customers
6 suppliers → 100 countries
Network value: $41.2M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Glibenclamide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Glibenclamide.
- 2.Flow Mapping: 194 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 930 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 100 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
930 Verified Shipments
194 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists